- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (713)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (1)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5417)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2023 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang LF, Chen PR, He SK, Duan SH, Zhang Y. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review. World J Gastroenterol 2023; 29(29): 4481-4498 [PMID: 37621757 DOI: 10.3748/wjg.v29.i29.4481] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v29/i29/4481.htm |
| Number | Citing Articles |
| 1 |
Moushira Zaki, Hisham A. Orban, Marwa Mahmoud, Eman R. Youness, Hoda F. Booles, Wagdy K. B. Khalil, Wafaa Wafy, Kamal A. El-Atrebi, Khaled Hamed, Hala T. El-Bassyouni. Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-α as a marker of disease severity. Egyptian Journal of Medical Human Genetics 2024; 25(1) doi: 10.1186/s43042-024-00533-2
|
| 2 |
Yue Yang, Kan-Zuo Fu, Gu Pan. Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis. World Journal of Gastrointestinal Surgery 2024; 16(1): 228-238 doi: 10.4240/wjgs.v16.i1.228
Abstract(290) |
Core Tip(313) |
Full Article(HTML)(923)
|
Full Article with Cover (PDF)-3312K(48)
|
Full Article (Word)-1272K(13)
|
Audio-338K(3)
|
Peer-Review Report-177K(33)
|
Answering Reviewers-115K(32)
|
Supplementary Material-213K(34)
|
Full Article (PDF)-3033K(70)
|
Full Article (XML)-117K(30)
|
Times Cited (4)
|
Total Visits (3215)
|
Open
|
| 3 |
Ji-Eun Na, Yong-Eun Park, Jong-Ha Park, Tae-Oh Kim, Jong-Yoon Lee, Jong-Hoon Lee, Su-Bum Park, Seung-Bum Lee, Seung-Min Hong. Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study. Journal of Personalized Medicine 2024; 14(10): 1066 doi: 10.3390/jpm14101066
|
| 4 |
Nikil Vootukuru, Abhinav Vasudevan. Approach to loss of response to advanced therapies in inflammatory bowel disease. World Journal of Gastroenterology 2024; 30(22): 2902-2919 doi: 10.3748/wjg.v30.i22.2902
|
| 5 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|